EU to push forward the internationalization of Chinese medicine
EU to push forward the internationalization of Chinese medicine
By the State led by Shang Yong, vice minister of Science and Technology, with many domestic Chinese pharmaceutical company to participate in the Chinese delegation composed by the Chinese Ministry of Science and the Italian Ministry of Health, the EU Directorate General for Research jointly sponsored the "International Cooperation and Prospects" is the theme Central European Congress of Chinese Medicine Day
Ago in Rome, Italy, this is the first time in Europe, the results show the development of Chinese medicine and Western biomedical sector for the exchange and cooperation.
The meeting, Chinese medicine and modern life science, biotechnology, organic combination of Western medicine, is bound to the human response to the challenges of major diseases to provide a new way. Representatives of participating parties to promote the internationalization of Chinese medicine to determine the focus of such scientific and technological cooperation reached consensus.
The participants affirmed the value of Traditional Chinese Medicine
Representatives of all participants reached consensus on four points. First, traditional Chinese medicine that originated in the achievements of human civilization, the Chinese nation to the whole of Eastern philosophy, based on system theory and dialectics is a practical system of biological medicine, is a unique advantage of knowledge systems and life science diagnosis and treatment system. With modern life science, biotechnology, organic combination of Western Western, will challenge the human response to provide a way of major diseases.
Second, Chinese medicine services in the world, must be based on greater innovation and development. In addition, policies and regulations to create a good environment is an important guarantee for cooperation. Enrich cooperative forms, such as the establishment of cooperative research and development funds, the establishment of bilateral or multilateral Chinese Medicine Clinical Research Center, joint laboratories, attention to intellectual property protection and reasonable share, will effectively promote innovation and links between the two sides Chan Xueyan to promote talent and information exchange, sharing of innovative results. Finally, the EU co-operation of Chinese medicine is very complementary, there is a good foundation, will achieve a win-win results, make a model of international cooperation.
5 cooperation for development of Chinese medicine
The meeting identified cooperation between China and the EU in five key medical technology content. First, strengthen scientific principles and mechanism of Chinese medicine collaborative research. With the focus on mental diseases, cardiovascular diseases, cancer, AIDS and other major ailments and conduct of Chinese medicine, health care prevention and clinical research. The second is to carry out joint research of Chinese medicine pharmacology, especially in Chinese medicine research and development of innovative drugs to cooperate. Third, to conduct Chinese medicine with international standards, norms and cooperation in the areas of policy. Fourth, bilateral or multilateral cooperation in substantive progress. Including the promotion of universities, research institutions, hospitals, business cooperation, build a number of bilateral or multilateral Chinese Medicine Clinical Research Center, joint laboratories, clinics and so on. Fifth, to promote Chinese culture in the international exchange and dissemination. Classical Chinese medicine, including medical books and academic publications order, universal, etc..
It is reported that, as an important step in promoting cooperation, by the end of November this year, the ministry will be held in Beijing, "China International Science & Technology Cooperation Conference." At the meeting, jointly sponsored with the countries concerned and to start "in the International Science & Technology Cooperation Plan", published in "International Cooperation of Chinese Medicine Beijing Declaration," set up "in the International Science & Technology Cooperation Programme," International Council of the Preparatory Committee and the Committee of Experts, established "International Network of Traditional Chinese Medicine Research Institute."
Chinese famous enterprises one step ahead
One of the conference delegates as well-known Chinese pharmaceutical company Hornsey also came the news of Italy, to the modernization and internationalization of traditional Chinese medicine than peer ahead.
It is reported that pharmaceuticals will be in Cambridge Hornsey area of cooperation initiated by the establishment of "Chinese medicine Hornsey Cambridge Center for International Studies." The project has been listed as the Ministry of Science, "International Cooperation in 2006 project." This is my first set up in foreign countries by the pharmaceutical research center of Chinese medicine.
WANG Yong-hui, chairman of Hornsey Pharmaceuticals, said "the Centre" will be based on the theory of Chinese medicine, combined with Hornsey company already has the related research, relying on China's scientific research strength, full use of Cambridge and the surrounding area a good research conditions to build a radiation function of research and development platform for the internationalization of Chinese medicine.
"Center" will Hornsey oral antiviral drugs and angiogenesis research focus on the mechanism of in-depth study of drug effects, and explore the establishment of Chinese medicine pharmacodynamics and safety evaluation of models and product standards, while promoting their own development to drive the technological progress of Chinese medicine manufacturing industry.
The establishment of the center of far-reaching significance. WANG Yong-hui said that, first of all can learn from the experience of the British Pharmaceutical Affairs for the state authorities to establish relevant standards, policies provide a useful reference, and Chinese medicine products for the enterprise, health care products to enter Europe and the United States to prepare for the international market. In addition, the "center" set up in Cambridge area, can be combined with the British advanced research methods and [FS: PAGE] scientific research, to use its good research environment and resources, and actively seek the guidance of the British Pharmaceutical Affairs Department, through its active interactive evaluation system for the establishment of Chinese medicines and products standard system to accumulate experience.
Centre is currently conducting research projects are: Hornsey antiviral mechanism of oral treatment, quality standards and improve further the development of new products; Danshen and its purified active components of angiogenesis, inhibition of two-way adjustment; Angelica active site for the treatment of endometriosis in women's studies and Chinese herbs, Chinese Herbal Medicine and extract an international standard research.
Christian Louboutin Drugstore Cowboy When Should You Hire A Medical Malpractice Attorney Fosamax medication, Fosamax drug Drug or Alcohol Detox and Addiction Old people need medical attention Christmas Bonuses And Drug Rehab Generic Equivalent Drugs Have The Ability To Cut Your Costs Did You Know They Tax Drugs? Check it Out Medical Negligence No Win No Fee Uses Of Gold In Medicine Cosmetic Surgeries: Medical Reasons For Plastic Surgery Just What Exactly Are Generic Drugs, And How Are They Different From Brand Name Medications? Are Anti - Stress And Anxiety Medicines The Best Respond To Your Stress Levels And Panic And Anxiety